Skip to content
DataLookout
Menu

NCT06995976

Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73

StatusCompleted
PhaseEarly Phase 1
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Minor Trial completed
    • Final enrollment: 15 participants (planned 30)
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

SUV of tumors
Timeframe: Through study completion, an average of 3 months

Secondary (1)

Diagnostic value

Arms and interventions

68Ga-dPNE PET/CTExperimental

Intravenous injection of 68Ga-dPNE. 68Ga-dPNE PET/CT will be used to detect tumors.

18F-FDG PET/CTExperimental

Intravenous injection of 18F-FDG. 18F-FDG PET/CT will be used to detect tumors.

Drugs: 68Ga-dPNE, 18F-FDG

Sites

1 site in 1 country

  • The First Affiliated Hospital of Fujian Medical UniversityFuzhou, Fujian, China